CNW/ - Hoffmann-La Roche Limited (Roche Canada) is pleased to announce, with support from the Government of Ontario through ...
In July, a single-judge bench of the Delhi High Court restrained Zydus Lifesciences from selling its breast cancer drug in ...
F. Hoffmann-La Roche Ltd. and Hoffmann-La Roche Inc. have patented oxazolo[4,5-B]pyrazine and oxazolo[4,5-B]pyridine derivatives acting as NLRP3 inflammasome inhibitors and reported to be useful for ...
However, in a newly published decision from an EPO board of appeal, T 56/21, the applicant (F. Hoffmann-La Roche AG) ...
Upholding the patent rights of Swiss pharmaceutical giant F-Hoffmann-La Roche AG, the Delhi High Court has once again ...
Key market participants include Thermo Fisher Scientific, Agilent Technologies, Abbott Laboratories, Danaher Corporation, Bio-Rad Laboratories Inc., QIAGEN, GE Healthcare, Hoffmann-La Roche AG, and ...
Idiopathic Membranous Nephropathy Treatment Market is projected to witness substantial growth over the next few years, driven ...